Alzex Neuropharma Inc. (TRRI)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0008 (-66.67%)
At close: Jul 14, 2026
Alzex Neuropharma Market Cap
Alzex Neuropharma has a market cap or net worth of $602 as of October 19, 2026. It is the 52,552nd most valuable company in the world and the 8,539th biggest in the United States. Its market cap has decreased by 99.44% in one year.
Market Cap
602.00
Enterprise Value
n/a
Revenue
4.73M
Global Rank
Country Rank
#8,539 United States
PE Ratio
0.02
ChartMarket Cap Chart
Since July 14, 2008, Alzex Neuropharma's market cap has decreased from 60.00K to 602.00, a decrease of -99.00%. That is a compound annual growth rate of -22.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 602.00 | 100.00% |
| Dec 30, 2025 | 301.00 | -99.90% |
| Dec 31, 2024 | 298.04K | -1.00% |
| Dec 14, 2023 | 301.05K | -9.09% |
| Dec 23, 2022 | 331.16K | -51.11% |
| Dec 28, 2021 | 677.37K | 857,331.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteonomix | 791.00 |
| Pathfinder Cell Therapy | 667.00 |
| U.S. Stem Cell | 662.00 |
| Amarantus BioScience Holdings | 630.00 |
| Adynxx | 581.00 |
| GlobeImmune | 575.00 |
| Mera Pharmaceuticals | 537.00 |
| Tetra Bio-Pharma | 516.00 |